Mercedes Benz Group AG (0NXX)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 39.90 |
|---|---|
| 52-week range | 38.88 – 62.34 |
| Return, 1 month / 3 months | −3.3% / −11.8% |
| Return, 1 year / 3 years | −25.9% / −16.9% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 30.51M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mercedes Benz Group AG is a German maker of cars and commercial vehicles based in Stuttgart. It builds passenger cars under the Mercedes-Benz and Maybach names, ranging from compact models to large saloons and sport utility vehicles, and it also produces vans, trucks and buses for business and transport customers. Its vehicles are sold through dealer networks in markets around the world, and the company also offers mobility and financial services connected to its vehicles.
On this site Mercedes Benz Group AG appears as a stock on the London Stock Exchange (UK), code 0NXX, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mercedes Benz Group AG (0NXX) trades on the London Stock Exchange in UK. It last closed at EUR 39.90 on 27 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 2,667 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.9% and over the last three months it fell 11.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.2% | ||
| From 52-week high | -35.4% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.8% | ||
| 6-month return | -19.4% | ||
| 12-month return, skipping the last month | -23.4% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 30.51M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | −3.3% |
| 3 months | −11.8% |
| 6 months | −19.4% |
| 1 year | −25.9% |
| 3 years | −16.9% |
| 5 years | −21.6% |
Signals
| 50-day / 200-day average | 43.21 / 49.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2025 | EUR 4.3000 |
| 9 May 2024 | EUR 5.3000 |
| 4 May 2023 | EUR 5.2000 |
| 3 May 2022 | EUR 5.0000 |
| 1 Apr 2021 | EUR 1.1307 |
| 9 Jul 2020 | EUR 0.7538 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.